Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden

References

• Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1–11.
   PubMed Web of Science ®Google Scholar
• Noltorp S, Svensson B. High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community. Clin Exp Rheumatol 1991;9:351–5.
   PubMed Web of Science ®Google Scholar
• Pamuk ON, Dönmez S, Karahan B, Pamuk GE, Cakir N. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: clinical features and epidemiological data. Clin Exp Rheumatol 2009;27:830–3.
   PubMed Web of Science ®Google Scholar
• Miller NR. Visual manifestations of temporal arteritis. Rheum Dis Clin North Am 2001;27:781–97, vi.
   PubMed Web of Science ®Google Scholar
• Kawasaki A, Purvin V. Giant cell arteritis: an updated review. Acta Ophthalmol 2009;87:13–32.
   PubMed Web of Science ®Google Scholar
• Fledelius HC, Nissen KR. Giant-cell arteritis and visual-loss – a 3-year retrospective hospital investigation in a Danish County. Acta Ophthalmol 1992;70:801–5.
   Web of Science ®Google Scholar
• Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum 2005;53:293–7.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998;125:509–20.
   PubMed Web of Science ®Google Scholar
• Hamrin B. Polymyalgia arteritica. Acta Med Scand Suppl 1972;533:1–131.
   PubMedGoogle Scholar
• Ji J, Sundquist J, Sundquist K. Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden. Br J Cancer 2015;112:149–52.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–72.
   PubMed Web of Science ®Google Scholar
• Breslow NE, Day NE. Statistical methods in cancer research. Volume II – the design and analysis of cohort studies. IARC Sci Publ 1987;82:1–406.
   Google Scholar
• Estève J, Benhamou E, Raymond L. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ 1994;1–302.
   Google Scholar
• Zöller B, Ji J, Sundquist J, Sundquist K. Alcohol use disorders are associated with venous thromboembolism. J Thromb Thrombolysis 2015;40:167–73.
   PubMed Web of Science ®Google Scholar
• Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, et al. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2015;74:1799–807.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim J-L, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
   PubMed Web of Science ®Google Scholar
• Egge K, Midtbo A, Westby R. Arteritis temporalis. Acta Ophthalmol (Copenh) 1966;44:49–56.
   PubMed Web of Science ®Google Scholar
• Hauser WA, Ferguson RH, Holley KE, Kurland LT. Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc 1971;46:597–602.
   PubMed Web of Science ®Google Scholar
• Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 1976;51:504–10.
   PubMed Web of Science ®Google Scholar
• Poller DN, Van Wyk Q, Jeffrey MJ. The importance of skip lesions in temporal arteritis. J Clin Pathol 2000;53:137–9.
   PubMed Web of Science ®Google Scholar
• Roth AM, Milsow L, Keltner JL. The ultimate diagnoses of patients undergoing temporal artery biopsies. Arch Ophthalmol 1984;102:901–3.
   PubMedGoogle Scholar
• Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 1991;34:351–6.
   PubMed Web of Science ®Google Scholar
• Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum 1981;24:899–904.
   PubMed Web of Science ®Google Scholar
• Singh AG, Kermani TA, Crowson CS, Weyand CM, Matteson EL, Warrington KJ. Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. J Rheumatol 2015;42:309–15.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, García-Porrúa C, Llorca J, Hajeer AH, Brañas F, Dababneh A, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79:283–92.
   PubMed Web of Science ®Google Scholar
• Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 2001;111:211–17.
   PubMed Web of Science ®Google Scholar
• Nir-Paz R, Gross A, Chajek-Shaul T. Sex differences in giant cell arteritis. J Rheumatol 2002;29:1219–23.
   PubMed Web of Science ®Google Scholar
• Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med 2014;12:182.
   PubMed Web of Science ®Google Scholar
• Ji J, Sundquist J, Sundquist K. Associations of alcohol use disorders with esophageal and gastric cancers: a population-based study in Sweden. Eur J Cancer Prev 2017;26:119–24.
   PubMed Web of Science ®Google Scholar